Ahmed M. Abbas

Asyut, AST, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications

Retraction notice to "Audit for quality of care and fate of maternal critical cases at Women's Health Hospital" [Applied Nursing Research 39 (2018) 175-181].

Retraction notice to "Audit for quality of care and fate of maternal critical cases at Women's Health Hospital" [Applied Nursing Research 39 (2018) 175-181].

Journal: Applied nursing research : ANR
Published: July 29, 2026

Retraction notice to "Prognostic accuracy of cerebroplacental ratio for adverse perinatal outcomes in pregnancies complicated with severe pre-eclampsia; a prospective cohort study" [Pregnancy Hypertension 14 (2018) 86-89].

Retraction notice to "Prognostic accuracy of cerebroplacental ratio for adverse perinatal outcomes in pregnancies complicated with severe pre-eclampsia; a prospective cohort study" [Pregnancy Hypertension 14 (2018) 86-89].

Journal: Pregnancy hypertension
Published: June 27, 2026

Retraction notice to "Topical lidocaine-prilocaine cream versus rectal meloxicam suppository for relief of post-episiotomy pain in primigravidae: A randomized clinical trial" [J Gynecol Obstet Hum Reprod 49/5 (2020) 101722].

Retraction notice to "Topical lidocaine-prilocaine cream versus rectal meloxicam suppository for relief of post-episiotomy pain in primigravidae: A randomized clinical trial" [J Gynecol Obstet Hum Reprod 49/5 (2020) 101722].

Journal: Journal of gynecology obstetrics and human reproduction
Published: April 23, 2026

RETRACTED: Oral Diclofenac Potassium Versus Hyoscine-N-Butyl Bromide in Reducing Pain Perception During Office Hysteroscopy: A Randomized Double-Blind Placebo-Controlled Trial[Journal of Minimally Invasive Gynecology Volume 26, Issue 4, May-June 2019, Pages 709-716].

RETRACTED: Oral Diclofenac Potassium Versus Hyoscine-N-Butyl Bromide in Reducing Pain Perception During Office Hysteroscopy: A Randomized Double-Blind Placebo-Controlled Trial[Journal of Minimally Invasive Gynecology Volume 26, Issue 4, May-June 2019, Pages 709-716].

Journal: Journal of minimally invasive gynecology
Published: April 19, 2026

Retraction notice to "Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation" [European Journal of Pharmaceutical Sciences 157 (2021)105602].

Retraction notice to "Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation" [European Journal of Pharmaceutical Sciences 157 (2021)105602].

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: March 29, 2026

Retraction notice to "Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective Cesarean section: A randomized double-blind clinical trial" [CONTRACEPTION 95 (2017) 538-543].

Retraction notice to "Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective Cesarean section: A randomized double-blind clinical trial" [CONTRACEPTION 95 (2017) 538-543].

Journal: Contraception
Published: March 25, 2026

Retraction notice to "Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: a randomized double-blind controlled trial" [CONTRACEPTION 95 (2017) 251-256].

Retraction notice to "Effect of cervical lidocaine-prilocaine cream on pain perception during copper T380A intrauterine device insertion among parous women: a randomized double-blind controlled trial" [CONTRACEPTION 95 (2017) 251-256].

Journal: Contraception
Published: January 30, 2026

Retraction notice to "A pilot study of a novel technique for hysteroscopic sterilization using the distal ends of a copper-T intrauterine device (Ostialoc)" [J Gynecol Obstet Hum Reprod 49 (2019) 101666].

Retraction notice to "A pilot study of a novel technique for hysteroscopic sterilization using the distal ends of a copper-T intrauterine device (Ostialoc)" [J Gynecol Obstet Hum Reprod 49 (2019) 101666].

Journal: Journal of gynecology obstetrics and human reproduction
Published: December 06, 2025

Retraction notice to "Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial" [J Gynecol Obstet Hum Reprod 48 (2018) 115-119].

Retraction notice to "Bilateral uterine artery ligation plus intravenous tranexamic acid during cesarean delivery for placenta previa: a randomized double-blind controlled trial" [J Gynecol Obstet Hum Reprod 48 (2018) 115-119].

Journal: Journal of gynecology obstetrics and human reproduction
Published: November 28, 2025

Retraction notice to "Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial" [J Gynecol Obstet Hum Reprod 49 (2019) 101728].

Retraction notice to "Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial" [J Gynecol Obstet Hum Reprod 49 (2019) 101728].

Journal: Journal of gynecology obstetrics and human reproduction
Published: November 28, 2025

Retraction notice to "Prediction of pelvic adhesions at repeat cesarean delivery through assessment of striae gravidarum score: A cross-sectional study" [J Gynecol Obstet Hum Reprod 49 (2019) 101619].

Retraction notice to "Prediction of pelvic adhesions at repeat cesarean delivery through assessment of striae gravidarum score: A cross-sectional study" [J Gynecol Obstet Hum Reprod 49 (2019) 101619].

Journal: Journal of gynecology obstetrics and human reproduction
Published: November 28, 2025

Retraction notice to "Comparison of the four malignancy risk indices in the discrimination of malignant ovarian masses: A cross-sectional study" [J Gynecol Obstet Hum Reprod 50 (2025) 101986].

Retraction notice to "Comparison of the four malignancy risk indices in the discrimination of malignant ovarian masses: A cross-sectional study" [J Gynecol Obstet Hum Reprod 50 (2025) 101986].

Journal: Journal of gynecology obstetrics and human reproduction
Published: September 04, 2025
Showing 1-12 of 156

Last Updated: 09/26/2026